The agent-first developer toolchain: how AI will radically transform the SDLC

Welcome Natasha, Amplify’s Head of Talent

Natasha will partner closely with our founding teams on strategic challenges and opportunities including developing best-in-class recruiting experiences that support employee engagement; identifying and scoping key hiring needs; coaching talent acquisition teams to optimize their hiring processes and other essential functions.

Datadog – Thank You and Congratulations

Congratulations to the Datadog team on your public debut today, it’s an incredible milestone.

Announcing Projects To Know

Each week, The Projects to Know newsletter will feature 3 academic papers and 3 open source projects that are playing a meaningful role in advancing machine intelligence and data science.

Startup Go-To-Market Checklist

A roadmap for an enterprise startup to assess what they had accomplished, and identify what remained to be done.

6 Steps To Navigating Enterprise Buying Patterns

When the data requirements of an organization change, data access must also change. When it comes time to make these changes, it’s rare to find an organization that doesn’t take into consideration existing legacy environments.

Congratulations Fastly! Reflecting on Seed to IPO

Congratulations to the entire team at Fastly on a successful initial public offering.

Welcoming Renee Shah, Amplify’s Newest Investor

I am excited to share the news that Renee Shah has joined Amplify’s investing team as a Principal focusing on our core investment themes in AI, machine learning, and intelligent applications.

Welcome Mark LaRosa

We’re elated to have Mark join us to bring his Liam Neeson-esque skills to Amplify where he’ll be working with our portfolio on everything from helping teams win their first set of key customers and outbound messaging to building their product roadmap.

Welcome Sergio Benitez

On behalf of everyone at Amplify, I am thrilled to announce that Sergio Benitez has joined us as an entrepreneur-in-residence.

Announcing InterVenn BioSciences

Today I am very excited to announce Amplify Partner’s investment in InterVenn BioSciences, a company leveraging mass spectrometry-based glycoproteomics and artificial intelligence to enable biomarker discovery and disease diagnosis.